Abbruzzese JL - Search Results

1

Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Hess KR, et al. Among authors: abbruzzese jl. Cancer. 2006 Apr 1;106(7):1624-33. doi: 10.1002/cncr.21778. Cancer. 2006. PMID: 16518827 Free article.

2

Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo.

Anzai H, Frost P, Abbruzzese JL. Anzai H, et al. Among authors: abbruzzese jl. Cancer Res. 1992 Apr 15;52(8):2180-5. Cancer Res. 1992. PMID: 1373105

3

Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.

Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B. Pazdur R, et al. Among authors: abbruzzese jl. Cancer. 1992 Oct 15;70(8):2073-6. doi: 10.1002/1097-0142(19921015)70:8<2073::aid-cncr2820700810>3.0.co;2-a. Cancer. 1992. PMID: 1394037 Clinical Trial.

4

Unknown primary tumors.

Raber MN, Abbruzzese JL, Frost P. Raber MN, et al. Among authors: abbruzzese jl. Curr Opin Oncol. 1992 Feb;4(1):3-9. Curr Opin Oncol. 1992. PMID: 1591292 No abstract available.

5

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin.

Raber MN, Faintuch J, Abbruzzese JL, Sumrall C, Frost P. Raber MN, et al. Among authors: abbruzzese jl. Ann Oncol. 1991 Jul;2(7):519-20. doi: 10.1093/oxfordjournals.annonc.a058007. Ann Oncol. 1991. PMID: 1911461 Free article. Clinical Trial.

6

Metastatic adenocarcinoma to the neck from an unknown primary source.

Lee NK, Byers RM, Abbruzzese JL, Wolf P. Lee NK, et al. Among authors: abbruzzese jl. Am J Surg. 1991 Oct;162(4):306-9. doi: 10.1016/0002-9610(91)90137-3. Am J Surg. 1991. PMID: 1951879

7

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, et al. Abbruzzese JL, et al. J Clin Oncol. 1991 Mar;9(3):491-8. doi: 10.1200/JCO.1991.9.3.491. J Clin Oncol. 1991. PMID: 1999720 Clinical Trial.

8

A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.

Ajani JA, Abbruzzese JL, Faintuch JS, Patt YZ, Boman BM, Jackson DE, Levin B, Krakoff IH. Ajani JA, et al. Among authors: abbruzzese jl. Cancer Invest. 1990;8(6):619-21. doi: 10.3109/07357909009018929. Cancer Invest. 1990. PMID: 2149834 Clinical Trial.

9

Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid.

Abbruzzese JL, Amato R, Schmidt S, Raber MN, Frost P. Abbruzzese JL, et al. Cancer Chemother Pharmacol. 1990;26(3):159-62. doi: 10.1007/BF02897192. Cancer Chemother Pharmacol. 1990. PMID: 2357761

10

Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.

Abbruzzese JL, Weeks A, Raber MN, Gravel D, DuBrow RA, Levin B, Grem J, Chun HG. Abbruzzese JL, et al. J Natl Cancer Inst. 1989 Dec 6;81(23):1840-2. doi: 10.1093/jnci/81.23.1840. J Natl Cancer Inst. 1989. PMID: 2585532 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters